11 November 2025
: Case report
Delayed-Onset Rhabdomyolysis of Bilateral Lower Extremities Following Statin Therapy in a 63-Year-Old Woman: A Case Report
Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy
Martin NguyenDOI: 10.12659/AJCR.948601
Am J Case Rep 2025; 26:e948601
Table 1 Results of autoimmune marker screening.
| Marker | Result* |
|---|---|
| Jo-1 Auto Ab | <0.2 |
| Anti-Jp-1 Ab | <20 |
| Anti-EJ Ab | Negative |
| Anti-Ku Ab | Negative |
| Anti-MDA-5 Ab | <20 |
| Anti-Mi-2 Ab | Negative |
| Anti-NXP-2 Ab | <20 |
| Anti-OJ Ab | Negative |
| Anti-PL-12 Ab | Negative |
| Anti-PL-7 Ab | Negative |
| Anti-PM/Scl-100 Ab | <20 |
| Anti-SAE1 Ab | <20 |
| Anti-SRP Ab | Negative |
| Anti-SS-A 52kD Ab | <20 |
| Anti-TIF-1 gamma Ab | <20 |
| Anti-U1 RNP Ab | <20 |
| Anti-U2 RNP Ab | Negative |
| Anti-U3 RNP Ab | Negative |
| * A negative test result is considered a normal reference value. Ab – antibody; Jo-1 Auto Ab – anti-histidyl-tRNA synthetase antibody; Anti-PL-7 Ab – anti-threonyl-tRNA synthetase antibody; Anti-PL-12 Ab – anti-alanyl-tRNA synthetase antibody; Anti-OJ Ab – anti-isoleucyl-tRNA synthetase antibody; Anti-Jp-1 Ab – anti-asparaginyl-tRNA synthetase antibody; Anti-EJ Ab – anti-glycyl-tRNA synthetase antibody; Anti-MDA-5 Ab – anti-melanoma differentiation-associated gene 5 antibody; Anti-NXP-2 Ab – anti-nuclear matrix protein 2 antibody; Anti-SAE1 Ab – anti-small ubiquitin-like modifier activating enzyme 1 antibody; Anti-SRP Ab – anti-signal recognition particle antibody; Anti-TIF-1 gamma Ab –anti-transcription intermediary factor 1 gamma antibody; RNP – ribonucleoprotein. | |






